ACTU: Actuate Therapeutics, Inc. Stock

SIC 7372 – Prepackaged Software

Valuation
Market Cap ($M) 172.46
Enterprise Value ($M) 158.94
Book Value ($M) 5.36
Book Value / Share 0.27
Price / Book 32.18
NCAV ($M) 5.36
NCAV / Share 0.27
Price / NCAV 32.18

Profitability (mra)
Return on Invested Capital (ROIC) -5.31
Return on Assets (ROA) -9.50
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.68
Current Ratio 1.68

Balance Sheet (mrq) ($M)
Current Assets 14.26
Assets 14.26
Liabilities 8.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
08-19 13D BIOS Fund I, LP 52.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 2,844 16,180 17.58
2025-01-30 1,006 8,393 11.99
2025-01-29 2,100 11,727 17.91
2025-01-28 2,164 15,351 14.10
2025-01-27 4,069 29,149 13.96

(click for more detail)

Similar Companies
AISP – Airship AI Holdings, Inc. APPF – AppFolio, Inc.


Financial data and stock pages provided by
Fintel.io